BioFish Holding AS Income Statement

Financials in millions NOK. Fiscal year is January - December.

Millions NOK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	48.89	47.68	20.24	18.33	30.92
Revenue Growth (YoY)	2.53%	135.55%	10.44%	-40.73%	-
Cost of Revenue	34.88	42.83	21.23	11.4	19.37
Gross Profit	14.01	4.85	-0.98	6.93	11.55
Selling, General & Admin	15.09	7.56	5.02	2.12	4.3
Other Operating Expenses	8.79	6.7	9.24	12.28	-
Operating Expenses	36.58	20.51	14.77	14.8	4.72
Operating Income	-22.56	-15.66	-15.75	-7.87	6.83
Interest Expense	-7.03	-1.77	-0.88	-0.13	-
Interest & Investment Income	-	-	-	0.09	1.94
Currency Exchange Gain (Loss)	0.01	-	-	-	-
Other Non Operating Income (Expenses)	0	-0.4	0.15	-0	-
Pretax Income	-29.59	-17.83	-16.48	-7.91	8.77
Income Tax Expense	-	0	-1.59	-2.12	1.96
Net Income	-29.59	-17.83	-14.89	-5.79	6.81
Net Income to Common	-29.59	-17.83	-14.89	-5.79	6.81
Shares Outstanding (Basic)	110	88	13	-	-
Shares Outstanding (Diluted)	110	88	13	-	-
Shares Change (YoY)	24.86%	559.17%	-	-	-
EPS (Basic)	-0.27	-0.20	-1.11	-	-
EPS (Diluted)	-0.27	-0.20	-1.11	-	-
Free Cash Flow	-23.87	-64.77	-44.6	-100.82	-
Free Cash Flow Per Share	-0.22	-0.73	-3.33	-	-
Gross Margin	28.66%	10.18%	-4.85%	37.80%	37.35%
Operating Margin	-46.15%	-32.83%	-77.78%	-42.95%	22.09%
Profit Margin	-60.52%	-37.39%	-73.56%	-31.57%	22.04%
Free Cash Flow Margin	-48.82%	-135.84%	-220.32%	-550.03%	-
EBITDA	-9.87	-9.41	-15.25	-7.47	7.25
EBITDA Margin	-20.19%	-19.73%	-75.31%	-40.77%	23.46%
D&A For EBITDA	12.69	6.25	0.5	0.4	0.42
EBIT	-22.56	-15.66	-15.75	-7.87	6.83
EBIT Margin	-46.15%	-32.83%	-77.78%	-42.95%	22.09%
Effective Tax Rate	-	-	-	-	22.30%
Revenue as Reported	-	-	-	18.33	-

Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.